Hillard CJ et al. |
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. |
1995 |
Biochim. Biophys. Acta |
pmid:7647100
|
Fride E et al. |
Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7853184
|
Romero J et al. |
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. |
1995 |
Pharmacol. Biochem. Behav. |
pmid:7675852
|
Das SK et al. |
Cannabinoid ligand-receptor signaling in the mouse uterus. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7753807
|
Fan P |
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. |
1995 |
J. Neurophysiol. |
pmid:7760148
|
Ueda N et al. |
Oxygenation of arachidonylethanolamide (anandamide) by lipoxygenases. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732825
|
Facci L et al. |
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7724569
|
Hampson AJ et al. |
Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. |
1995 |
Biochim. Biophys. Acta |
pmid:7488638
|
Ueda N et al. |
Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. |
1995 |
J. Biol. Chem. |
pmid:7559559
|
Venance L et al. |
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. |
1995 |
Nature |
pmid:7637807
|
Ueda N |
[Anandamide: an endogenous cannabinoid receptor agonist]. |
1995 |
Seikagaku |
pmid:7594870
|
Varga K et al. |
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. |
1995 |
Eur. J. Pharmacol. |
pmid:7589169
|
Mechoulam R et al. |
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. |
1995 |
Biochem. Pharmacol. |
pmid:7605349
|
Felder CC et al. |
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. |
1995 |
Mol. Pharmacol. |
pmid:7565624
|
Vela G et al. |
Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. |
1995 |
Neuropharmacology |
pmid:7566503
|
Paria BC et al. |
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7568154
|
Burstein SH and Hunter SA |
Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC). |
1995 |
Biochem. Pharmacol. |
pmid:7702643
|
Priller J et al. |
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. |
1995 |
Mol. Pharmacol. |
pmid:7651362
|
Pertwee RG et al. |
Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. |
1995 |
Eur. J. Pharmacol. |
pmid:7713152
|
Hansen HS et al. |
Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. |
1995 |
Biochim. Biophys. Acta |
pmid:7548201
|